StockData
Omeros Corp logo

Omeros Corp (OMER) stock

OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$13.92−2.76 (-16.55%)

Close on Nov 17, 2026Market cap $1.01BP/E –Yield –

Omeros total assets

Total assets on the balance sheet at the end of each period.

Omeros's total assets was $286.83M at Jun 30, 2026. For fiscal 2025 it was $325.63M, up 17.5% from the year before. Over ten years it grew 20.9% a year on average. The highest annual figure on record is $590.97M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$325.63M+17.5%
FY2024Dec 31, 2024$277.08M-26.8%
FY2023Dec 31, 2023$378.27M-36.0%
FY2022Dec 31, 2022$590.97M+41.0%
FY2021Dec 31, 2021$419.27M+131.6%
FY2020Dec 31, 2020$181.04M+32.2%
FY2019Dec 31, 2019$136.97M+42.8%
FY2018Dec 31, 2018$95.94M-17.5%
FY2017Dec 31, 2017$116.33M+72.9%
FY2016Dec 31, 2016$67.28M+37.3%
FY2015Dec 31, 2015$49.00M+352.2%
FY2014Dec 31, 2014$10.83M-34.5%
FY2013Dec 31, 2013$16.54M-37.8%
FY2012Dec 31, 2012$26.58M-1.5%
FY2011Dec 31, 2011$26.98M-41.0%
FY2010Dec 31, 2010$45.70M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$286.83M+43.0%
Q1 FY2026Mar 31, 2026$286.17M+21.7%
Q4 FY2025Dec 31, 2025$325.63M+17.5%
Q3 FY2025Sep 30, 2025$185.71M-40.7%
Q2 FY2025Jun 30, 2025$200.57M-43.7%
Q1 FY2025Mar 31, 2025$235.16M-46.2%
Q4 FY2024Dec 31, 2024$277.08M-26.8%
Q3 FY2024Sep 30, 2024$313.34M-36.5%
Q2 FY2024Jun 30, 2024$356.31M-32.4%
Q1 FY2024Mar 31, 2024$437.49M-21.9%
Q4 FY2023Dec 31, 2023$378.27M-36.0%
Q3 FY2023Sep 30, 2023$493.07M+7.8%
Q2 FY2023Jun 30, 2023$527.42M+52.6%
Q1 FY2023Mar 31, 2023$560.13M+51.7%
Q4 FY2022Dec 31, 2022$590.97M+41.0%
Q3 FY2022Sep 30, 2022$457.55M+270.7%
Q2 FY2022Jun 30, 2022$345.64M+114.1%
Q1 FY2022Mar 31, 2022$369.26M+104.0%
Q4 FY2021Dec 31, 2021$419.27M+84.6%
Q3 FY2021Sep 30, 2021$123.43M+74.6%
Q1 FY2021Mar 31, 2021$161.44M+36.6%
Q4 FY2020Dec 31, 2020$181.04M+32.2%
Q3 FY2020Sep 30, 2020$227.08M+148.8%
Q2 FY2020Jun 30, 2020$70.69M-21.2%
Q1 FY2020Mar 31, 2020$118.21M+16.8%
Q4 FY2019Dec 31, 2019$136.97M+42.8%
Q3 FY2019Sep 30, 2019$91.26M+20.7%
Q2 FY2019Jun 30, 2019$89.76M-15.6%
Q1 FY2019Mar 31, 2019$101.25M+13.7%
Q4 FY2018Dec 31, 2018$95.94M-17.5%
Q3 FY2018Sep 30, 2018$75.61M-39.8%
Q2 FY2018Jun 30, 2018$106.35M+76.2%
Q1 FY2018Mar 31, 2018$89.04M+52.4%
Q4 FY2017Dec 31, 2017$116.33M+72.9%
Q3 FY2017Sep 30, 2017$125.52M+72.5%
Q2 FY2017Jun 30, 2017$60.35M+30.9%
Q1 FY2017Mar 31, 2017$58.40M–
Q4 FY2016Dec 31, 2016$67.28M–
Q3 FY2016Sep 30, 2016$72.76M–
Q2 FY2016Jun 30, 2016$46.11M–

More Omeros figures

See a number that looks wrong?